• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染性原发性主动脉瘤手术治疗后预防血管移植物或腔内移植物感染的抗生素策略分析:一项系统评价

Analysis of antibiotic strategies to prevent vascular graft or endograft infection after surgical treatment for infective native aortic aneurysms: a systematic review.

作者信息

Wu Shye-Jao, Sun Shen, Tan Yu-Hern, Chien Chen-Yen

机构信息

Division of Cardiovascular Surgery, Departments of Surgery, MacKay Memorial Hospital, Taipei, Taiwan.

MacKay Medical College, New Taipei, Taiwan.

出版信息

Antimicrob Resist Infect Control. 2024 Oct 1;13(1):116. doi: 10.1186/s13756-024-01477-3.

DOI:10.1186/s13756-024-01477-3
PMID:39354648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11446112/
Abstract

INTRODUCTION

Some patients with an infective native aortic aneurysm (INAA) develop an aortic vascular graft or endograft infection (VGEI) even after successful open surgical repair or endovascular intervention. The aim of the systematic review and meta-analysis performed herein was to compare the clinical outcomes of different surgical and antibiotic treatment strategies.

METHODS

We systematically searched PubMed, MEDLINE, EMBASE and Web of Science. The keywords used for the search were "mycotic aortic aneurysm", "infected aortic aneurysm", "infective native aortic aneurysm", "antibiotics", "surgery", and "endovascular". The search was limited to articles written in English and to studies involving humans. Articles published before 2000 were excluded. Case reports and review articles were excluded.

RESULTS

Of the 524 studies retrieved from our search of the databases, 47 articles were included in this study. Among the 47 articles (1546 patients, 72.8% of whom were male) retrieved, five articles were excluded from the subgroup analysis because the data concerning open surgical repair and endovascular intervention could not be separated. The remaining 42 articles included a total of 1179 patients who underwent open surgical repair (622 patients) or endovascular intervention (557 patients) for INAA. There was a statistically significant difference (p = 0.001) in the pooled in-hospital mortality rate between the open surgical repair group (13.2%, 82/622) and the endovascular intervention group (7.2%, 40/557). However, there was a statistically significant difference (p < 0.001) in the aortic VGEI rate between the open surgical repair group (5.4%). 29/540) and endovascular intervention (13.3%, 69/517) group. For patients who underwent open surgical repair, a lower rate of aortic vascular graft infection was associated with long-term antibiotic use (p = 0.005). For patients who underwent endovascular intervention, there was a trend of association (p = 0.071) between the lower rate of aortic endograft infection and lifelong antibiotic use.

CONCLUSION

Infective native aortic aneurysms are life-threatening. The pooled in-hospital mortality rate of the open surgical repair group was significantly higher than that of the endovascular intervention group, whereas the rate of the aortic VGEI in the open surgical repair group was significantly lower than that in the endovascular intervention group. Regardless of whether open surgical repair or endovascular intervention is performed, better long-term outcomes can be achieved with aggressive antibiotic treatment, which is especially important for patients who undergo endovascular intervention.

摘要

引言

一些感染性原发性主动脉瘤(INAA)患者即使在成功进行开放手术修复或血管内介入治疗后仍会发生主动脉血管移植物或腔内移植物感染(VGEI)。本系统评价和荟萃分析的目的是比较不同手术和抗生素治疗策略的临床结果。

方法

我们系统检索了PubMed、MEDLINE、EMBASE和科学网。搜索所用关键词为“霉菌性主动脉瘤”“感染性主动脉瘤”“感染性原发性主动脉瘤”“抗生素”“手术”和“血管内”。搜索仅限于用英文撰写的文章和涉及人类的研究。排除2000年以前发表的文章。排除病例报告和综述文章。

结果

在我们检索数据库获得的524项研究中,本研究纳入了47篇文章。在检索到的47篇文章(1546例患者,其中72.8%为男性)中,5篇文章被排除在亚组分析之外,因为有关开放手术修复和血管内介入治疗的数据无法分开。其余42篇文章共纳入1179例因INAA接受开放手术修复(622例患者)或血管内介入治疗(557例患者)的患者。开放手术修复组(13.2%,82/622)和血管内介入治疗组(7.2%,40/557)的合并住院死亡率存在统计学显著差异(p = 0.001)。然而,开放手术修复组(5.4%,29/540)和血管内介入治疗组(13.3%,69/517)的主动脉VGEI发生率存在统计学显著差异(p < 0.001)。对于接受开放手术修复的患者,长期使用抗生素与较低的主动脉血管移植物感染率相关(p = 0.005)。对于接受血管内介入治疗的患者,较低的主动脉腔内移植物感染率与终身使用抗生素之间存在关联趋势(p = 0.071)。

结论

感染性原发性主动脉瘤危及生命。开放手术修复组的合并住院死亡率显著高于血管内介入治疗组,而开放手术修复组的主动脉VGEI发生率显著低于血管内介入治疗组。无论进行开放手术修复还是血管内介入治疗,积极的抗生素治疗均可取得更好的长期效果,这对接受血管内介入治疗的患者尤为重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0785/11446112/9592748fb17a/13756_2024_1477_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0785/11446112/9592748fb17a/13756_2024_1477_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0785/11446112/9592748fb17a/13756_2024_1477_Fig1_HTML.jpg

相似文献

1
Analysis of antibiotic strategies to prevent vascular graft or endograft infection after surgical treatment for infective native aortic aneurysms: a systematic review.感染性原发性主动脉瘤手术治疗后预防血管移植物或腔内移植物感染的抗生素策略分析:一项系统评价
Antimicrob Resist Infect Control. 2024 Oct 1;13(1):116. doi: 10.1186/s13756-024-01477-3.
2
Methicillin-resistant Staphylococcus aureus portends a poor prognosis after endovascular repair of mycotic aortic aneurysms and aortic graft infections.耐甲氧西林金黄色葡萄球菌预示着血管内修复真菌性主动脉瘤和主动脉移植物感染后的预后不良。
J Vasc Surg. 2020 Jul;72(1):276-285. doi: 10.1016/j.jvs.2019.08.274. Epub 2019 Dec 13.
3
Endograft Infection After Endovascular Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis.血管内腹主动脉瘤修复术后移植物感染:系统评价和荟萃分析。
J Endovasc Ther. 2017 Oct;24(5):688-697. doi: 10.1177/1526602817722018. Epub 2017 Jul 31.
4
Endovascular repair of descending thoracic aortic aneurysm: an evidence-based analysis.降主动脉瘤的血管腔内修复:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(18):1-59. Epub 2005 Nov 1.
5
The relevance of aortic endograft prosthetic infection.主动脉内移植物假体感染的相关性。
J Vasc Surg. 2011 Aug;54(2):327-33. doi: 10.1016/j.jvs.2010.12.067. Epub 2011 Mar 11.
6
Neoaortic Xenoprosthetic Grafts for Treatment of Mycotic Aneurysms and Infected Aortic Grafts.用于治疗感染性动脉瘤和感染性主动脉移植物的新型主动脉异种移植人工血管
Ann Vasc Surg. 2017 Oct;44:419.e1-419.e12. doi: 10.1016/j.avsg.2017.02.021. Epub 2017 Jun 20.
7
The management of endograft infections following endovascular thoracic and abdominal aneurysm repair.胸腹部血管内动脉瘤修复术后带血管移植物感染的管理。
J Vasc Surg. 2013 Nov;58(5):1179-85. doi: 10.1016/j.jvs.2013.04.040. Epub 2013 Jul 4.
8
Current Evidence on Management of Aortic Stent-graft Infection: A Systematic Review and Meta-Analysis.主动脉覆膜支架感染管理的当前证据:一项系统评价和荟萃分析
Ann Vasc Surg. 2018 Aug;51:306-313. doi: 10.1016/j.avsg.2018.02.038. Epub 2018 Jun 11.
9
Fenestrated endovascular grafts for the repair of juxtarenal aortic aneurysms: an evidence-based analysis.用于修复近肾主动脉瘤的开窗型血管内移植物:循证分析
Ont Health Technol Assess Ser. 2009;9(4):1-51. Epub 2009 Jul 1.
10
[Management of Endograft Infection After EVAR and TEVAR - a Case Series and Literature Review].[腔内修复术后人工血管感染的处理——病例系列研究与文献综述]
Zentralbl Chir. 2017 Oct;142(5):506-515. doi: 10.1055/s-0043-119997. Epub 2017 Oct 27.

本文引用的文献

1
Infective Native Aortic Aneurysm: a Delphi Consensus Document on Treatment, Follow Up, and Definition of Cure.感染性自体主动脉瘤:治疗、随访和治愈定义的德尔菲共识文件。
Eur J Vasc Endovasc Surg. 2024 Apr;67(4):654-661. doi: 10.1016/j.ejvs.2023.12.008. Epub 2023 Dec 13.
2
Editor's Choice - Infective Native Aortic Aneurysms: A Delphi Consensus Document on Terminology, Definition, Classification, Diagnosis, and Reporting Standards.编辑推荐——感染性原发性主动脉瘤:关于术语、定义、分类、诊断及报告标准的德尔菲共识文件
Eur J Vasc Endovasc Surg. 2023 Mar;65(3):323-329. doi: 10.1016/j.ejvs.2022.11.024. Epub 2022 Dec 5.
3
Early and late outcomes of surgical repair of mycotic aortic aneurysms: A 30-year experience.
外科手术治疗感染性主动脉瘤的早期和晚期结果:30 年经验。
J Thorac Cardiovasc Surg. 2024 Feb;167(2):578-587. doi: 10.1016/j.jtcvs.2022.03.029. Epub 2022 Apr 8.
4
Patient-Tailored Approach for Diagnostics and Treatment of Mycotic Abdominal Aortic Aneurysm.个体化方法在真菌性腹主动脉瘤的诊断和治疗中的应用。
Ann Vasc Surg. 2022 Aug;84:225-238. doi: 10.1016/j.avsg.2022.01.006. Epub 2022 Jan 31.
5
Fifteen-year, single-center experience with in situ reconstruction for infected native aortic aneurysms.15 年单中心原位重建治疗感染性自体主动脉瘤的经验。
J Vasc Surg. 2022 Mar;75(3):950-961.e5. doi: 10.1016/j.jvs.2021.08.094. Epub 2021 Sep 30.
6
The Microbiology of Infective Native Aortic Aneurysms in a Population-Based Setting.基于人群的感染性原发性主动脉瘤的微生物学研究。
Ann Vasc Surg. 2022 Jan;78:112-122. doi: 10.1016/j.avsg.2021.06.039. Epub 2021 Sep 17.
7
Early and Midterm Outcomes of Endovascular Repair of Tuberculous Infected Native (Mycotic) Aortic Aneurysms.结核感染性原发性(霉菌性)主动脉瘤血管内修复的早期和中期结果
Eur J Vasc Endovasc Surg. 2021 Aug;62(2):314-315. doi: 10.1016/j.ejvs.2021.05.003. Epub 2021 Jun 6.
8
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
9
Mycotic Abdominal Aortic Aneurysms - A Tertiary Centre Experience and Formulation of a Management Protocol.真菌性腹主动脉瘤——一家三级医疗中心的经验和管理方案制定。
Ann Vasc Surg. 2021 Jul;74:246-257. doi: 10.1016/j.avsg.2020.12.025. Epub 2021 Jan 26.
10
Endovascular treatment for mycotic aneurysm using pyoktanin- applied devices.使用含碘番酸的装置对霉菌性动脉瘤进行血管内治疗。
CVIR Endovasc. 2020 Nov 8;3(1):55. doi: 10.1186/s42155-020-00151-0.